Stoke Therapeutics
IPORestoring protein expression with RNA medicine.
Stoke Therapeutics was founded in 2014, is headquartered in Bedford, United States, lists 201–500 employees, and has $130.0M in recorded funding across 2 rounds.
- Headquarters
- Bedford, Massachusetts
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Website
- stoketherapeutics.com
- Total Funding
- $130.0M
- Last Round
- $90.0M Series BOct 2018
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Stoke Therapeutics (Nasdaq: STOK) is a clinical-stage biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Founded in 2014 and headquartered in Bedford, Massachusetts, the company pioneered the TANGO (Targeted Augmentation of Nuclear Gene Output) approach, which uses antisense oligonucleotides (ASOs) to selectively increase the productive splicing of pre-mRNA, thereby boosting the expression of proteins encoded by haploinsufficient genes. Stoke's lead program, zorevunersen (STK-001), targets Dravet syndrome, a severe and treatment-resistant genetic epilepsy caused by haploinsufficiency of the SCN1A gene. The company has also applied its platform to other neurological conditions including SYNGAP1-related intellectual disability. With a pipeline built on a foundational understanding of RNA biology, Stoke aims to address a broad range of genetic diseases where restoring even partial protein expression could meaningfully improve patient outcomes.
Summary
Stoke Therapeutics is a Biotech company based in Bedford, United States, founded in 2014. It lists 201–500 employees. It has raised $130.0M in total across 2 rounds, most recently a $90.0M Series B round in Oct 2018. Investors include RTW Investments and Apple Tree Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2018
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/stoke-therapeutics"><img src="https://indexed.vc/api/badge/company/stoke-therapeutics" alt="Stoke Therapeutics on Indexed.vc" width="260" height="76" /></a>